Annonaceous acetogenins, a large family of naturally occurring
polyketides isolated from various species of the plant genus Annonaceae, have been found to exhibit significant cytotoxicity against a variety of
cancer cells. Previous studies showed that these compounds could act on the mitochondria complex-I and block the corresponding electron transport chain and terminate
ATP production. However, more details of the mechanisms of action remain ambiguous. In this study we tested the effects of a set of mimetics of annonaceous acetogenin on some
cancer cell lines, and report that among them
AA005 exhibits the most potent antitumor activity.
AA005 depletes
ATP, activates
AMP-activated protein kinase (AMPK) and inhibits mTOR complex 1 (
mTORC1) signal pathway, leading to growth inhibition and autophagy of
colon cancer cells. AMPK inhibitors compound C and
inosine repress, while AMPK activator
AICAR enhances, AA005-caused proliferation suppression and subsequent autophagy of
colon cancer cells.
AA005 enhances the
ATP depletion and AMPK activation caused by
2-deoxyglucose, an inhibitor of mitochondrial respiration and glycolysis.
AA005 also inhibits chemotherapeutic agent
cisplatin-triggered up-regulation of mTOR and synergizes with this
drug in suppression of proliferation and induction of apoptosis of
colon cancer cells. These data indicate that
AA005 is a new metabolic inhibitor which exhibits therapeutic potentials in
colon cancer.